- JP-listed companies
- JCR Pharmaceuticals Co.,Ltd.
- Income statement
JCR Pharmaceuticals Co.,Ltd.【JP:4552】Income statement
Market cap
¥91.7B
P/E ratio
29.2x
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 12,845 | 14,100 | 15,706 | 16,856 | 17,438 | 18,085 | 20,594 | 23,160 | 24,781 | 30,085 | 51,082 | 34,343 | 42,871 | 33,072 |
| Cost of revenue | - | - | - | 5,741 | 6,459 | 5,732 | 6,128 | 6,567 | 7,901 | 7,812 | 10,461 | 8,886 | 11,620 | 11,333 |
| Gross profit | - | - | - | 11,115 | 10,979 | 12,353 | 14,465 | 16,592 | 16,880 | 22,272 | 40,620 | 25,456 | 31,251 | 21,738 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | - | - | 2,015 | 2,153 | 2,362 | 3,784 | 4,967 | 3,244 | 8,269 | 19,933 | 4,975 | 7,531 | -6,650 |
| Operating expenses | - | - | - | 9,100 | 8,826 | 9,991 | 10,681 | 11,625 | 13,635 | 14,003 | 20,686 | 20,480 | 23,719 | 28,389 |
| Income before tax | 1,005 | 1,156 | 1,681 | 2,340 | 2,443 | 2,534 | 3,843 | 5,068 | 3,293 | 8,488 | 20,512 | 5,418 | 7,264 | -7,477 |
| Provision for income taxes | - | - | - | 652 | 670 | 630 | 825 | 1,217 | 742 | 1,764 | 4,886 | 1,625 | 1,707 | -1,718 |
| Net income | 650 | 553 | 1,180 | 1,682 | 1,790 | 1,863 | 3,070 | 3,715 | 2,679 | 6,892 | 14,517 | 3,787 | 5,536 | -4,695 |
| Earnings per share | 19.75 | 23.03 | 40.79 | 52.85 | 56.12 | 58.95 | 98.73 | 120.68 | 86.89 | 55.81 | 117.26 | 30.35 | 44.13 | -38.43 |
| Diluted EPS | 19.69 | 22.92 | 40.52 | 52.53 | 55.81 | 58.61 | 98.11 | 119.96 | 86.36 | 55.53 | 116.8 | 30.22 | 43.92 | - |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | - | - | ||||
| Dividend per share | 12 | 12 | 17 | 18.5 | 22 | 22 | 26 | 30 | 32 | 25.5 | 22 | 20 | 20 | 20 |